• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30

Advanced Prostate Cancer Consensus Conference

Advanced Prostate Cancer Consensus Conference

In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, molecular characterization, and genetic assays have led to many open questions and areas for which there is sparse or low-level evidence to support clinical decision-making. 

The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum to discuss and debate current questions on the clinical management of men with advanced prostate cancer, with a special focus on these unclear situations. Two days of the conference are dedicated to high-level presentations, discussions, and debates to summarize and conceptualize the available literature and evidence.

The conference concludes with voting by an interdisciplinary expert panel on pre-defined consensus questions targeting areas of clinical relevance. Following the conference, a manuscript with these expert recommendations is published in a peer-reviewed journal (Annals of Oncology in 2015; European Urology in 2017).


Aims of APCCC

  • Provide an update on the current standard of advanced prostate cancer management with a focus on situations with no high level evidence for a specific treatment option.
  • Advanced prostate cancer is defined by APCCC as locally advanced disease, biochemical recurrence, and metastatic disease.
  • Offer a highly educational program consisting of invited lectures, debates, and discussions led by a panel of international and interdisciplinary prostate cancer experts.
  • Translate knowledge by summarising and conceptualising current standards of advanced prostate cancer management and disseminating the results of consensus discussions and voting.
  • At the end of the meeting, convene these experts to discuss and vote on predefined questions regarding key areas of debate or lack of evidence regarding the optimal treatment of men with advanced prostate cancer. The conference and the development of these questions have been described in detail (see APCCC 2015 and APCCC 2017)
  • After the meeting, publish the consensus summary in a high-impact medical journal.
  • Conference attendees will be able to participate in the two days of discussions as well as the consensus panel discussion. Attendees are encouraged to interact with panel members to facilitate and encourage international collaboration.

Event Properties

Event Date 29 Aug 2019
Event End Date 31 Aug 2019
Capacity Unlimited
Name of the Organizer:
Person of Contact
Location Basel
We are no longer accepting registration for this event